Greenwich LifeSciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€13.60M +77.6% N/A -€6.26M +12.2% N/A
    €0.00 +NaN% -€7.66M +16.8% N/A -€5.58M +4.5% N/A
    €0.00 +NaN% -€6.56M +67.5% N/A -€5.34M +44.5% N/A
    €0.00 +NaN% -€3.91M +144.0% N/A -€3.70M +272.2% N/A
    €0.00 +NaN% -€1.60M -45.6% N/A -€993.33K +293.1% N/A
    €0.00 +NaN% -€2.95M +102.7% N/A -€252.66K +155.1% N/A
    €0.00 +NaN% -€1.46M +7.4% N/A -€99.04K -4.9% N/A
    €0.00 -€1.36M N/A -€104.12K N/A

    Notifications